Dec 26, 2024 by Adam Spatacco Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical ...

Dec 26, 2024 by Adam Spatacco Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, ...

Molson Coors Beverage Company will host a webcast of the company's 2024 Fourth Quarter and Full Year Earnings Conference Call with investors and financial analysts at 8:30 a.m. Eastern Time on ...

Novo Nordisk petitions the FDA to exclude liraglutide from the 503B Bulks List, citing safety risks, lack of clinical need, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

As previously reported, Bernstein upgraded Novo Nordisk (NVO) to Market Perform from Underperform with a price target of DKK 600, up from DKK ...

Berenberg lowered the firm’s price target on Novo Nordisk (NVO) to DKK 725 from DKK 975 and keeps a Hold rating on the shares.Don't Miss Our ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn ...

Novo Nordisk also boasted a 55.6% share of the GLP-1 drug space, compared to 54.4% as of August 2023. The company's most famous brands, Wegovy and Ozempic, are both GLP-1s.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...